Physician profile
Robert W Cooper
NPI 1194729525
$1,910.70
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $340 · 2021: $467 · 2022: $626 · 2023: $295 · 2024: $78.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $373.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $372.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $327.90 | 2020-2023 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $195.80 | 2022-2023 | |
| Amgen INC. | $190.07 | 2019-2022 | |
| Novo Nordisk INC | $170.55 | 2019-2024 | Ozempic, Rybelsus |
| Abbvie INC. | $164.95 | 2021-2024 | Vraylar |
| Glaxosmithkline, LLC. | $156.77 | 2020-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbott Laboratories | $152.69 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $116.33 | 2022 | |
| Allergan, INC. | $99.37 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $59.08 | 2022 | |
| Medtronic, INC. | $47.90 | 2024 | Minimed 780g |
| Biohaven Pharmaceuticals, INC. | $39.27 | 2021 | |
| Evoke Pharma, INC. | $37.14 | 2022-2023 | Gimoti |
| Takeda Pharmaceuticals U.S.A., INC. | $30.08 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.80 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $27.01 | 2020-2021 | |
| Otsuka America Pharmaceutical, INC. | $23.86 | 2023 | Rexulti |
| Nestle Healthcare Nutrition INC. | $18.01 | 2021 | |
| Lilly USA, LLC | $15.33 | 2023 | Mounjaro |
| Amarin Pharma, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.